何氏眼科
(301103)
| 流通市值：31.70亿 | | | 总市值：31.70亿 |
| 流通股本：1.58亿 | | | 总股本：1.58亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 855,274,926.4 | 560,092,655.12 | 291,475,651.27 | 1,095,633,818.01 |
| 营业收入 | 855,274,926.4 | 560,092,655.12 | 291,475,651.27 | 1,095,633,818.01 |
| 二、营业总成本 | 786,489,696.96 | 505,466,143.59 | 249,890,953.57 | 1,092,731,743.26 |
| 营业成本 | 497,546,294.7 | 324,503,332.43 | 163,805,191.42 | 672,647,617.19 |
| 税金及附加 | 4,099,661.75 | 2,601,626.41 | 1,416,884.15 | 8,282,285.14 |
| 销售费用 | 124,073,553.86 | 79,760,169.6 | 38,332,856.94 | 182,460,680.23 |
| 管理费用 | 149,424,009.31 | 93,836,929.78 | 44,765,062.74 | 218,648,746.79 |
| 研发费用 | 10,475,430.11 | 6,120,724.03 | 2,814,695.66 | 18,105,528.86 |
| 财务费用 | 870,747.23 | -1,356,638.66 | -1,243,737.34 | -7,413,114.95 |
| 其中:利息费用 | 6,763,696.5 | 4,606,772.4 | 2,343,629.65 | 11,338,074.36 |
| 其中:利息收入 | 7,543,782.72 | 6,962,143.99 | 4,118,655.75 | 21,199,207.2 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 722,074.95 | 1,869,969.56 | -410,570.3 | 993,033.59 |
| 加:投资收益 | 9,739,729.44 | 4,032,222.49 | 1,339,625.23 | 453,353.14 |
| 资产处置收益 | -122,027.41 | -70,009.14 | -12,569.43 | 1,399,235.42 |
| 资产减值损失(新) | 24,452.79 | -546,141.14 | -415,816.42 | -1,694,352.48 |
| 信用减值损失(新) | -602,274.21 | -514,600.57 | -385,075.47 | -1,295,103.13 |
| 其他收益 | 3,136,453.08 | 2,633,787.69 | 660,753.56 | 3,402,244.35 |
| 四、营业利润 | 81,683,638.08 | 62,031,740.42 | 42,361,044.87 | 6,160,485.64 |
| 加:营业外收入 | 470,530.09 | 292,761.8 | 132,441.02 | 208,660.13 |
| 减:营业外支出 | 1,687,115.36 | 1,256,561.98 | 267,708.26 | 4,741,983.91 |
| 五、利润总额 | 80,467,052.81 | 61,067,940.24 | 42,225,777.63 | 1,627,161.86 |
| 减:所得税费用 | 26,909,094.53 | 17,500,523.03 | 11,567,173.34 | 36,903,019.51 |
| 六、净利润 | 53,557,958.28 | 43,567,417.21 | 30,658,604.29 | -35,275,857.65 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 53,557,958.28 | 43,567,417.21 | 30,658,604.29 | -35,275,857.65 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 54,395,334.2 | 44,324,593.65 | 32,531,877.2 | -27,398,159.61 |
| 少数股东损益 | -837,375.92 | -757,176.44 | -1,873,272.91 | -7,877,698.04 |
| 扣除非经常损益后的净利润 | 42,428,730.55 | 37,241,675.29 | 31,189,504.57 | -28,787,671.23 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.34 | 0.28 | 0.21 | -0.17 |
| (二)稀释每股收益 | 0.34 | 0.28 | 0.21 | -0.17 |
| 八、其他综合收益 | -12,246.02 | -19,381.89 | 591,621.26 | 3,764.36 |
| 归属于母公司股东的其他综合收益 | -12,246.02 | -19,381.89 | 591,621.26 | 3,764.36 |
| 九、综合收益总额 | 53,545,712.26 | 43,548,035.32 | 31,250,225.55 | -35,272,093.29 |
| 归属于母公司股东的综合收益总额 | 54,383,088.18 | 44,305,211.76 | 33,123,498.46 | -27,394,395.25 |
| 归属于少数股东的综合收益总额 | -837,375.92 | -757,176.44 | -1,873,272.91 | -7,877,698.04 |
| 公告日期 | 2025-10-30 | 2025-08-28 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |